Investor Notes - Phillip Securities (HK) Ltd
Past Investor Notes  
Phillip Home Send to Friends Free Subscription Give Comments 中文版
24 May, 2019 (Friday)

            
UM HEALTHCARE(2138))
Analysis:
According to the positive profit alert of Union Medical Healthcare (2138), it is expected that the financial results of the Group for the year ended 31 March 2019 may record a significant increase of over 35% in both revenue and profit after tax. The Group continues to diversify its services and product offerings, thus fueling growth in customer spending, in particular its PRC customers. As at 1 November 2018, the Group operated 54 clinics and services centres with 80 registered practitioners across Hong Kong, Macau and the PRC. In August 2018, the Group entered into an agreement with Tencent Doctorwork to jointly establish care clinics in Hong Kong and co-invest and develop IT system to connect medical services across the PRC and Hong Kong. (I do not hold the above stock)
Strategy:
Buy-in Price: $5.30, Target Price: $5.80, Cut Loss Price: $5.05


WUXI APPTEC(2359)
Analysis:
WuXi AppTech announced on May 6, 2019 that it successfully acquired Pharmapace, a US clinical research services company. The company provides high-quality statistical analysis services for all phases of clinical trials, registration and post-marketing support. Upon completion of the acquisition, Pharmapace will become a wholly-owned subsidiary of WuXi CDS, a clinical CRO company of WuXi AppTech, and will continue to focus on expanding its core statistical analysis services capabilities. In the future, Pharmapace will integrate with WuXi CDS`s related clinical research services business. After the acquisition of Pharmapace, WuXi CDS has a service team of more than 850 people in China and the United States, together with the company`s strategic partners in Europe and Asia Pacific, they will provide a full range of clinical development services and Functional Service Provision to customers around the world. As China`s National Medical Products Administration (NMPA) announces acceptance of overseas clinical trial data, the company`s new clinical service capabilities in both China and the United States will attract more domestic and foreign customers.
Strategy:
Buy-in Price: $83.00, Target Price: $95.52, Cut Loss Price: $81.027


The Global X Millennials Thematic ETF ( MILN )
The Global X Millennials Thematic ETF is a thematic ETF with market cap of approximately USD 46.11 million and expense ratio of 0.5%. The ETF provides exposure to companies that are determined to have significant revenue from the millennial generation's spending habits. Spending categories include clothing, entertainment, travel, food, education, financial services, housing, and health. “Millennials” refers to the U.S population born approximately between 1980 & 2000, aged 16 -35. According to the research from Global X, millennials account for one quarter of the nation's population and are positioned to become a strong part of workforce within U.S economy. 75 percent of total workforce was accounted by Millennials. It is expected that there is USD 40 trillion transfer of wealth from baby boomer generation to Millennials. To differential its behavior characteristics, millennials are tech savvy, socially connected and values experience. MILN enables investors to access high growth potential through companies which benefit from millennial demand. Suggested to buy at $24.16, target price $26.1, cut loss if drop below $23.50.



Travelsky Technology (696.HK) - United States trade war resumed, Airline industry will suffer in the short term

Investment Summary

Travelsky Technology is the largest provider of the aviation information systems in China, which developed systems, such as flight control, air ticket distribution, check-in, boarding and load planning, accounting, settlement and clearing system, and aviation logistic. Based on DCF valuation, we derived a TP of HK$23.74, implied a P/E of 24.5x and 22x in 2019/20F. We maintain a “Buy” rating with a potential upside of 42.8%. (Closing price at 20 May 2019)

The pessimistic outlook on economy and depreciation on RMB reduce the number of tourists and freight transport volume in China in the short term

As the China - United States trade war resumed, the number of tourists and freight transport volume in China may reduce due to the pessimistic outlook on economy and depreciation on RMB. The China - United States trade war was reignited, after the US urged to raise the tax rate from 10% to 25% for goods from China worth USD 200 bn on 6 May and officially came into effect on 10 May. China also retaliated by imposing a tax rise on goods from US worth USD 60bn. If the intensity of conflict between US and China remains or goes up, it will definitely drive down their economic growth, or even the global economic growth. Besides, the depreciation on RMB could somehow alleviate the effect of tax rise from US side, which could maintain the competitiveness of the Chinese export. The RMB has depreciated by 2.7% in since May, reaching the previous bottom in 2017.

As the pessimistic outlook on economy and depreciation on RMB, the willingness to travel for Chinese may reduce. First, traveling is attributed to the discretionary spending, implying that it is vulnerable to the economic cycle. If the economy is heading into a recession, the number of travelling may reduce. Second, the depreciation on RMB lowers the purchasing power of Chinese travelers in foreign countries, which may eventually reduce their willingness to travel.

If the number of tourists drops, it would reduce the bookings through the Group's systems, thereby lowering the revenue of Group. The recession may also reduce the freight transport volume, which will affect the revenue from Accounting, Settlement and Cleaning Services.

However, we believe the number of traveling will remain its uptrend in the long term despite the shocks in the short term , thanks to the increase in GDP per capita. Once the monopoly due to the protection from the Civil Aviation Administration remains, the Group will be the only company that benefits from this uptrend in number of travelling.

At present, some of the impacts can be seen from the operational data released by the group. Although the number of bookings for Chinese commercial airlines increased by 7.74% YoY from January to April, and the number of foreign and regional commercial airlines` bookings increased by 8.95% YoY. However, the growth rate of bookings for Chinese commercial airlines in March and April were the lowest in nine years, only 3.3% and 4.3%. The trade war was reignited in May, so the operating data for the next few months may remain low.

Spring Airlines adopted Travelsky's computer reservation system (CRS)

The Group released on May 15 that Spring Airlines has adopted their computer reservation system (CRS) - eTerm, implying that the travel agents will be able to purchase the air ticket of Spring Airlines via the Group's CRS.

Previously, Spring Airlines mainly sold their ticket through their own website. However, as its size became larger and the increase in international flights, direct sales will not be able to cope with the volume. As a result, Spring Airlines decided to adopt the Group's CRS.

Although Spring Airlines did not adopt the Group's Inventory Control System (ICS), the system we believe creates the greatest competitive advantage, the cooperation still could enhance the competitiveness of the Group's Global Distribution System (GDS).

Earnings Forecast

We lower our revenue growth forecast in 2019/20F by 1.1%/0.46%, to 9.2%/10.6%, reflecting the pessimistic outlook on Chinese economy and depreciation on RMB, but we should see the growth resume to normal in the long term.

Valuation

We adopted the DCF model for valuation, where we assume the discount rate to be 9.76%, and terminal growth to be 2.5%, with FCFF forecast to 2028F. We derived a TP of HK$23.75, implied a P/E of 24.5x and 22x in 2019/20F, 6.8% lower than our previous TP, due to the pessimistic outlook on Chinese economy and depreciation on RMB. We believe the investment ground in the long term still remains, but may suffer in the short term due to the intensified trade war. In view of the plunge in stock price, we maintain a “Buy” rating with a potential upside of 42.8%. (HKD/CNY=0.887)

Risk

1. Economic downturn

2. Aviation system market opening up

3. Airlines develop their own systems

Financials

Click Here for PDF format...




Recommendation on 24-5-2019
RecommendationBuy
Price on Recommendation Date$ 16.620
Suggested purchase priceN/A
Target Price$ 23.740
Writer Info
Terry Li
(Research Analyst)
Tel: +852 2277 6527
Email:
terryli@phillip.com.hk

Local Index
       Index    Change   Change%

World Index
       Index    Change   Change%
  

A-H spread
Stock Code H share
Price
A share
Price
H share
discount


Oversea Research Reports


Investment Service Centre



Enquiry : 2277 6666 OR investornotes@phillip.com.hk
If you cannot read this e-mail in the proper format, please click here to view the web version.

Information contained herein is based on sources that Phillip Securities (Hong Kong) Limited and/or its affiliates ( the “Group”) believe to be accurate. The Group does not bear responsibility for any loss occasioned by reliance placed upon the contents hereof. The Group (or its employees) may have interests in relevant investment products. For details of different products’ risks, please view the Risk Disclosures Statement on http://www.phillip.com.hk.

If you DO NOT wish to receive further marketing emails from us, please click HERE to opt-out.

版權所有, 翻印必究。

Copyright(C) 2019 Phillip Securities (HK) Ltd. All Rights Reserved.